These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20031674)

  • 21. Percutaneous intervention for unprotected left main disease prior to explantation of a left ventricular assist device.
    Butman SM; Jamison K; Slepian M; Edling N; Arabia F; Copeland JG
    Catheter Cardiovasc Interv; 2003 Aug; 59(4):471-4. PubMed ID: 12891610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
    Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P
    Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous coronary intervention for unprotected left main coronary artery stenosis.
    Park SJ; Kim YH
    Cardiol Clin; 2010 Feb; 28(1):81-95. PubMed ID: 19962051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stenting unprotected left main: the outcome is not always favorable.
    Colombo A
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):539-40. PubMed ID: 18307235
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
    Patel MR; Pfisterer ME; Betriu A; Widmisky P; Holmes DR; O'Neill WW; Stebbins A; Van de Werf F; Armstrong PW; Granger CB;
    Am J Cardiol; 2009 Jan; 103(2):181-6. PubMed ID: 19121433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of diabetes mellitus on early and long-term results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease.
    Sheiban I; Garrone P; Sillano D; Biondi-Zoccai G; Sciuto F; Omedè P; Lombardi P; Meliga E; Anselmino M; Trevi GP; Moretti C
    J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1246-53. PubMed ID: 19001932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stenting of unprotected left main coronary artery stenosis.
    Barlis P; Wong MC; Clark DJ
    Heart Lung Circ; 2007; 16 Suppl 3():S34-8. PubMed ID: 17606402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous coronary intervention or coronary artery bypass graft for unprotected left main coronary artery disease: the endless debate.
    Meliga E; Valgimigli M; Buszman P; Serruys PW
    J Am Coll Cardiol; 2008 Aug; 52(7):582-4; author reply 584-6. PubMed ID: 18687257
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical results of unprotected left main coronary stenting.
    Ben-Dor I; Vaknin-Assa H; Lev E; Brosh D; Fuchs S; Assali A; Kornowski R
    Isr Med Assoc J; 2009 Mar; 11(3):154-9. PubMed ID: 19544705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug-eluting stent implantation for unprotected left main coronary artery disease: immediate and long-term outcomes].
    Zhang LT; Yuan Y; Huang XS; Feng L; Liu WQ; Han Y; Zhang J; Deng ZH; Dong JT
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2257-9. PubMed ID: 19114374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
    Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C
    Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).
    Huang HW; Brent BN; Shaw RE
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):867-72. PubMed ID: 17080468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes.
    Tamburino C; Di Salvo ME; Capodanno D; Palmerini T; Sheiban I; Margheri M; Vecchi G; Sangiorgi G; Piovaccari G; Bartorelli A; Briguori C; Ardissino D; Di Pede F; Ramondo A; Inglese L; Petronio AS; Bolognese L; Benassi A; Palmieri C; Filippone V; De Servi S
    Am J Cardiol; 2009 Jan; 103(2):187-93. PubMed ID: 19121434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk.
    Wood FO; Saylors EK; Schneider JE; Jobe RL; Mann JT
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):533-8. PubMed ID: 18307224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-eluting stents in ST elevation myocardial infarction: In light of the PROSIT trial.
    Kornowski R
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):33-5. PubMed ID: 18561153
    [No Abstract]   [Full Text] [Related]  

  • 36. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry.
    Chieffo A; Park SJ; Valgimigli M; Kim YH; Daemen J; Sheiban I; Truffa A; Montorfano M; Airoldi F; Sangiorgi G; Carlino M; Michev I; Lee CW; Hong MK; Park SW; Moretti C; Bonizzoni E; Rogacka R; Serruys PW; Colombo A
    Circulation; 2007 Jul; 116(2):158-62. PubMed ID: 17576862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcome of patients with chronic total occlusion treated with drug-eluting stents.
    De Felice F; Fiorilli R; Parma A; Menichelli M; Nazzaro MS; Pucci E; Dibra A; Musto C; Violini R
    Int J Cardiol; 2009 Mar; 132(3):337-41. PubMed ID: 18234373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug eluting stents in AMI: keep the data coming.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2008 May; 71(6):770-1. PubMed ID: 18412075
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug-eluting stents in multivessel coronary artery disease: Was one of the important fortresses of surgery conquered?].
    Okmen AS; Okmen E
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):325-30. PubMed ID: 19666436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry.
    Abbott JD; Voss MR; Nakamura M; Cohen HA; Selzer F; Kip KE; Vlachos HA; Wilensky RL; Williams DO
    J Am Coll Cardiol; 2007 Nov; 50(21):2029-36. PubMed ID: 18021868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.